HK1009751A1 - Antifungal agent compound therefor process for producing the same - Google Patents

Antifungal agent compound therefor process for producing the same

Info

Publication number
HK1009751A1
HK1009751A1 HK98110741A HK98110741A HK1009751A1 HK 1009751 A1 HK1009751 A1 HK 1009751A1 HK 98110741 A HK98110741 A HK 98110741A HK 98110741 A HK98110741 A HK 98110741A HK 1009751 A1 HK1009751 A1 HK 1009751A1
Authority
HK
Hong Kong
Prior art keywords
producing
same
antifungal agent
agent compound
compound therefor
Prior art date
Application number
HK98110741A
Other languages
English (en)
Inventor
Hiroki Kodama
Yoshimi Niwano
Kazuo Kanai
Masanori Yoshida
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of HK1009751A1 publication Critical patent/HK1009751A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK98110741A 1995-07-08 1998-09-18 Antifungal agent compound therefor process for producing the same HK1009751A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19617495 1995-07-08
PCT/JP1996/001872 WO1997002821A2 (en) 1995-07-08 1996-07-05 Antifungal agent, compound therefor, process for producing the same

Publications (1)

Publication Number Publication Date
HK1009751A1 true HK1009751A1 (en) 1999-06-11

Family

ID=16353435

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98110741A HK1009751A1 (en) 1995-07-08 1998-09-18 Antifungal agent compound therefor process for producing the same

Country Status (22)

Country Link
US (1) US5900488A (es)
EP (1) EP0839035B1 (es)
KR (1) KR100386491B1 (es)
CN (1) CN1091596C (es)
AT (1) AT407832B (es)
CA (1) CA2226214C (es)
CH (1) CH692045A5 (es)
DE (1) DE19681478B4 (es)
DK (1) DK176599B1 (es)
ES (1) ES2137888B1 (es)
FI (1) FI119357B (es)
GB (1) GB2317615B (es)
HK (1) HK1009751A1 (es)
IL (1) IL122618A (es)
IN (1) IN185384B (es)
LU (1) LU90190B1 (es)
NO (1) NO980055L (es)
NZ (1) NZ311796A (es)
SE (1) SE9800016L (es)
TW (1) TW450969B (es)
WO (1) WO1997002821A2 (es)
ZA (1) ZA965745B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127397A (en) * 1996-12-10 2000-10-03 Nihon Nohyaku Co., Ltd. Optically active (R)-(E)-(4-substituted-phenyl-1,3-dithiolan-2-ylidene)-1-imidazolylaceto nitrile derivative, antifungal composition comprising the same, and method for producing the same
AU2003242235A1 (en) * 2002-06-18 2003-12-31 Pola Chemical Industries Inc. Antifungal medicinal composition
EP1537868B1 (en) * 2002-06-18 2011-08-24 Pola Pharma Inc. Antifungal medicinal compositions
EP2005959B1 (en) * 2006-03-08 2015-01-21 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
JP5160409B2 (ja) * 2006-03-08 2013-03-13 日本農薬株式会社 外用の医薬組成物
MX2008011433A (es) 2006-03-08 2008-09-18 Nihon Nohyaku Co Ltd Composicion farmaceutica para uso externo.
JP5313905B2 (ja) * 2007-08-27 2013-10-09 日本農薬株式会社 真菌性皮膚炎用剤
WO2009031643A1 (ja) 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌組成物
PL2191828T3 (pl) 2007-09-05 2017-02-28 Pola Pharma Inc. Przeciwgrzybicza kompozycja farmaceutyczna
CN101808637B (zh) * 2007-09-05 2013-07-24 宝丽制药股份有限公司 医药组合物
CN102395274B (zh) * 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2010117091A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
KR101754697B1 (ko) 2009-08-25 2017-07-06 가부시키가이샤 폴라 파마 항진균성 약제학적 조성물
US8962669B2 (en) 2010-06-11 2015-02-24 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN103012385B (zh) * 2012-02-17 2015-07-08 山东威智医药工业有限公司 卢立康唑的晶型及其制备方法
WO2014041708A1 (en) * 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal
IN2015DN02929A (es) * 2012-09-14 2015-09-18 Pola Pharma Inc
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
CN104619704B (zh) * 2012-09-14 2017-12-05 宝丽制药股份有限公司 表面自由能用于分化评价晶体的用途,基于表面自由能作为指标评价的晶体,以及通过包含所述晶体制备的药物组合物
US20150352078A1 (en) * 2013-01-28 2015-12-10 Pola Pharma Inc. Pharmaceutical composition for diseases caused by pathogenic microorganisms such as candida
EP2948145A1 (en) * 2013-01-28 2015-12-02 Pola Pharma Inc. Pharmaceutical composition for diseases caused by pathogenic microorganisms such as aspergillus
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
WO2015162271A1 (en) * 2014-04-25 2015-10-29 Syngenta Participations Ag Microbiocidal imidazole derivatives
WO2016092478A1 (en) 2014-12-12 2016-06-16 Glenmark Pharmaceuticals Limited Process for preparation of luliconazole
WO2017108972A1 (en) 2015-12-21 2017-06-29 Laboratorios Lesvi, S.L. Compounds of r-(-)-(e)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1 -imidazolylacetonitrile-ha (luliconazole-ha) as antifungals
CN106008166B (zh) * 2016-05-17 2018-09-25 上海福乐医药科技有限公司 一种手性2-氯-1-(2,4-二氯苯基)乙醇的工业化生产方法
US11185548B2 (en) 2016-12-23 2021-11-30 Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases
TR201714882A2 (tr) 2017-10-03 2019-04-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
US10898470B1 (en) 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
WO2023131969A1 (en) * 2022-01-09 2023-07-13 Kimia Biosciences Limited Improved process for the preparation of luliconazole

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218736B1 (en) * 1985-10-10 1993-04-07 Nihon Nohyaku Co., Ltd. A ketene s,s-acetal derivative, a process for manufacturing thereof and a method for curing mycosis by administering it
DE3587252T2 (de) * 1985-10-09 1993-07-15 Nihon Nohyaku Co Ltd Keten-s,s,-acetalderivate, verfahren zu ihrer herstellung und methode zur heilung von mykose unter verwendung dieser derivate.
JP3030780B2 (ja) * 1988-12-29 2000-04-10 日本農薬株式会社 光学活性なケテンジチオアセタール誘導体及びその製造方法
JPH0386337A (ja) * 1989-08-28 1991-04-11 Maeda Seisakusho:Kk エクスパンディングチャックを用いた多重巻締め機および多重巻締め方法
CN1038247C (zh) * 1990-05-16 1998-05-06 云南省建筑材料科学研究设计院 一种新型磷石膏胶结料
JP3038519B2 (ja) * 1992-01-28 2000-05-08 日本農薬株式会社 創傷治癒促進剤

Also Published As

Publication number Publication date
LU90190B1 (de) 1998-03-02
NO980055D0 (no) 1998-01-06
FI980023A0 (fi) 1998-01-07
IN185384B (es) 2001-01-13
AT407832B (de) 2001-06-25
NZ311796A (en) 1999-06-29
ZA965745B (en) 1997-01-27
CN1194582A (zh) 1998-09-30
IL122618A0 (en) 1998-08-16
DE19681478B4 (de) 2006-09-21
WO1997002821A2 (en) 1997-01-30
DE19681478T1 (de) 1998-07-02
EP0839035B1 (en) 2002-10-02
IL122618A (en) 2002-07-25
AU697571B2 (en) 1998-10-08
SE9800016D0 (sv) 1998-01-07
KR100386491B1 (ko) 2003-08-21
GB2317615A (en) 1998-04-01
SE9800016L (sv) 1998-01-07
CA2226214C (en) 2007-04-17
GB9726766D0 (en) 1998-02-18
CH692045A5 (de) 2002-01-15
KR19990028772A (ko) 1999-04-15
ES2137888A1 (es) 1999-12-16
EP0839035A2 (en) 1998-05-06
CA2226214A1 (en) 1997-01-30
US5900488A (en) 1999-05-04
FI980023A (fi) 1998-01-07
WO1997002821A3 (en) 1997-02-20
ES2137888B1 (es) 2001-01-01
ATA906196A (de) 2000-11-15
NO980055L (no) 1998-03-06
CN1091596C (zh) 2002-10-02
DK1398A (da) 1998-01-07
FI119357B (fi) 2008-10-31
GB2317615B (en) 1998-09-02
AU6319296A (en) 1997-02-10
TW450969B (en) 2001-08-21
MX9710401A (es) 1998-07-31
DK176599B1 (da) 2008-10-27

Similar Documents

Publication Publication Date Title
GB2317615B (en) Antifungal agent compound therefor process for producing the same
IL134322A0 (en) A process for the preparation of an intermediate for the preparation of imidazole compounds
CZ252597A3 (cs) Způsob výroby azacyklohexapeptidů
EP0676800A3 (en) Process for the production of metal-bonded ceramic materials or components.
EP0819759A4 (en) FUNGICIDAL TERPENIC COMPOUNDS AND PROCESS FOR THEIR PRODUCTION
GB2277518B (en) Process for producing trialkoxysilanes
SG81886A1 (en) Tetraphenol compounds & process for producing the same
EP0765890A3 (en) Process for the preparation of a rubber composition
EP0753500A3 (en) Process for the preparation of ethers
AU2807595A (en) Novel triazole compound, process for producing the same, and pest control agent
EP0789040A4 (en) PROCESS FOR PRODUCING POLYOXYMETHYLENE
EP0688770A3 (en) Process for the preparation of hydroxyflavans compounds
SG38905A1 (en) Process for the manufacture of hydroxyalkoxybenzophenones
EP0682034A3 (en) Process for the preparation of cyanoalkylorganooxysilanes from cyanoalkylchlorosilanes.
ZA9610053B (en) Process for preparing dioxoazabicyclohexanes.
ZA963192B (en) Process for making heterocyclic compounds.
GB2303849B (en) Process for making bicyclo-HMX
GR3030254T3 (en) Process for preparing substituted aminotriazolinones
EP0751112A3 (de) Verfahren zur Herstellung von Arylidensubstituierten Alkylcycloalkanonen
EP0694512A3 (de) Verfahren zur Herstellung von Hexafluor-C4-Verbindungen
EP0751111A3 (de) Verfahren zur Herstellung von 2,2-Dialkylaryliden-cycloalkanonen
HU9702176D0 (en) New process for producing lisinoprile
HUP9603478A2 (en) Process for making steel-moulding by aluminoterminating
HUP9801592A3 (en) Process for preparing substituted aryluracils
EP0684238A3 (en) Process for the preparation of dicarboxamides.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20160704